RegCell has tapped Michael McCullar, Ph.D., as its new president, CEO and representative director. McCullar previously served as the CEO of OnQuality Pharmaceuticals and has held leadership roles at Tolero Pharmaceuticals (acquired by Sumitomo Dainippon Pharma), Astex Pharmaceuticals (acquired by Otsuka Pharmaceuticals) and SuperGen.
